Fig. 3: Risk of all-cause mortality associated with antidepressant (AD) use compared to non-use of antidepressants in between-individual design. | Schizophrenia

Fig. 3: Risk of all-cause mortality associated with antidepressant (AD) use compared to non-use of antidepressants in between-individual design.

From: Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects

Fig. 3: Risk of all-cause mortality associated with antidepressant (AD) use compared to non-use of antidepressants in between-individual design.The alternative text for this image may have been generated using AI.

Adjusted hazard ratios (aHRs) with 95% Confidence Intervals (CIs). Polytherapy refers to the concomitant use of two or more antidepressants. Other ADs include the rest of the antidepressants marketed in Finland.

Back to article page